Literature DB >> 20518607

Surgical management of Parkinson's disease.

Thomas Foltynie1, Marwan I Hariz.   

Abstract

There has been a renaissance in the surgical treatment of Parkinson's disease (PD) over the last 15-20 years as a result of the long-term complications of L-DOPA use. The current cornerstone of surgical treatment for PD is high-frequency deep-brain stimulation (DBS) of the subthalamic nucleus (STN) using implantable electrodes and an implantable pulse generator/battery. Among well-selected patients, that is, patients with idiopathic PD, L-DOPA-responsive symptoms and no significant psychiatric comorbidities or cognitive decline, STN DBS can provide improvements in motor symptoms and quality of life, with low risks of adverse effects. In this article, we briefly describe the evolution of surgical treatments for PD, and the rationale for current DBS procedures. We also provide details of our practice, including patient selection, surgical technique and postoperative stimulation programming and medication adjustment. Current and possible future alternatives to DBS of the STN are also discussed.

Entities:  

Mesh:

Year:  2010        PMID: 20518607     DOI: 10.1586/ern.10.68

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  41 in total

1.  Functional anatomy of subthalamic nucleus stimulation in Parkinson disease.

Authors:  Sarah A Eisenstein; Jonathan M Koller; Kathleen D Black; Meghan C Campbell; Heather M Lugar; Mwiza Ushe; Samer D Tabbal; Morvarid Karimi; Tamara Hershey; Joel S Perlmutter; Kevin J Black
Journal:  Ann Neurol       Date:  2014-07-02       Impact factor: 10.422

2.  Advanced research on deep brain stimulation in treating mental disorders.

Authors:  Dongxin Wang; Xuejun Liu; Bin Zhou; Weiping Kuang; Tiansheng Guo
Journal:  Exp Ther Med       Date:  2017-10-24       Impact factor: 2.447

Review 3.  Stem cell-based therapy as a promising approach in Alzheimer's disease: current perspectives on novel treatment.

Authors:  Saeid Bagheri-Mohammadi
Journal:  Cell Tissue Bank       Date:  2021-01-04       Impact factor: 1.522

Review 4.  Therapeutic applications of antibodies in non-infectious neurodegenerative diseases.

Authors:  Pavan K Krishnamurthy; Einar M Sigurdsson
Journal:  N Biotechnol       Date:  2011-04-05       Impact factor: 5.079

Review 5.  Cell replacement therapy is the remedial solution for treating Parkinson's disease.

Authors:  Venkatesan Dhivya; Vellingiri Balachandar
Journal:  Stem Cell Investig       Date:  2017-06-30

6.  Subthalamic nucleus activity optimizes maximal effort motor responses in Parkinson's disease.

Authors:  Anam Anzak; Huiling Tan; Alek Pogosyan; Thomas Foltynie; Patricia Limousin; Ludvic Zrinzo; Marwan Hariz; Keyoumars Ashkan; Marko Bogdanovic; Alexander L Green; Tipu Aziz; Peter Brown
Journal:  Brain       Date:  2012-08-01       Impact factor: 13.501

7.  Bilateral Deep Brain Stimulation of the Nucleus Basalis of Meynert for Parkinson Disease Dementia: A Randomized Clinical Trial.

Authors:  James Gratwicke; Ludvic Zrinzo; Joshua Kahan; Amy Peters; Mazda Beigi; Harith Akram; Jonathan Hyam; Ashwini Oswal; Brian Day; Laura Mancini; John Thornton; Tarek Yousry; Patricia Limousin; Marwan Hariz; Marjan Jahanshahi; Thomas Foltynie
Journal:  JAMA Neurol       Date:  2018-02-01       Impact factor: 18.302

8.  Subthalamic nucleus local field potential activity helps encode motor effort rather than force in parkinsonism.

Authors:  Huiling Tan; Alek Pogosyan; Keyoumars Ashkan; Binith Cheeran; James J FitzGerald; Alexander L Green; Tipu Aziz; Thomas Foltynie; Patricia Limousin; Ludvic Zrinzo; Peter Brown
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

Review 9.  Challenges in PD Patient Management After DBS: A Pragmatic Review.

Authors:  Malco Rossi; Verónica Bruno; Julieta Arena; Ángel Cammarota; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2018-02-28

10.  Comparison of oscillatory activity in subthalamic nucleus in Parkinson's disease and dystonia.

Authors:  Xinyi Geng; Jianguo Zhang; Yin Jiang; Keyoumars Ashkan; Thomas Foltynie; Patricia Limousin; Ludvic Zrinzo; Alexander Green; Tipu Aziz; Peter Brown; Shouyan Wang
Journal:  Neurobiol Dis       Date:  2016-12-07       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.